Emergent Biosolutions Inc
EBS
Get informed when a big investor buys or sells
+ FollowMarket Cap$321.44M
Close$
$-7.39
205.3% downside
Current Fair Value
205.3% downsideOvervalued by 205.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $321.44 Million |
|---|---|
| Enterprise Value | $778.54 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.98 |
| Beta | 2.34 |
| Outstanding Shares | 51,600,000 |
Return
| Return on Equity | -53.78% |
|---|---|
| Return on Assets | -16.44% |
| Return on Invested Capital | -3.05% |
Valuation & Multiples
| P/E Ratio | -1.81 |
|---|---|
| PEG | -0.13 |
| Price to Sales | 0.5 |
| Price to Book Ratio | 1.17 |
| Enterprise Value to Revenue | 1.01 |
| Enterprise Value to EBIT | -25.69 |
| Enterprise Value to Net Income | -5 |
| Total Debt to Enterprise | 0.77 |
| Debt to Equity | 1.75 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 5, 2026
EPS Estimate
$-0.09
Average shareholder expectationRevenue Estimate
$177.50 M
Average shareholder expectationNext Earnings Call
Expected Date
October 28, 2026
EPS Estimate
$-0.41
Average shareholder expectationRevenue Estimate
$209.00 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.3377▼ 5.21% |
|---|---|
| Total Calls | 456,600▲ 49.95% |
| Total Puts | 154,200▲ 29.91% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 88.74%▲ 5.05% |
|---|---|
| Total Invested | $383.71M▲ 6.39% |
| Investors Holding | 201▲ 5.00% |
ESG Score
No data
About Emergent Biosolutions Inc
CEO: Robert Kramer